SeekIn Inc.

Company Snapshot

Founded: 2018
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America
Corporate Address: 10320 Camino Santa Fe Suite G, San Diego California 92121 U.S. Tel. +1- www.seekincancer.com

Company Overview

SeekIn is developing liquid biopsy tests for early cancer detection. The company uses machine learning to train classifiers analyzing cfDNA to detect early signs of cancer.

SeekIn uses artificial intelligence to mine cfDNA data and create patterns of DNA alterations that are related to cancer. The company hopes to develop tests for recognizing in situ tumors, pre-cancers and aggressive cancers in asymptomatic people.

The objective is to develop a test that can be widely used across a broad population for screening purposes.

SeekIn Inc. In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Report for DNA Sequencing Industry. Global market for DNA sequencing technologies and their applications in research, applied and clinical segments.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Company's Business Segments

  • Oncology : This segment houses advanced sequencing and AI to rapidly detect blood-based pan-cancer. Moreover, the segment provides solutions for early cancer detection, treatment response evaluation, and postoperative recurrence monitoring.

Applications/End User Industries

  • Healthcare
AI Sentiment